Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
about
Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentHaploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma ProgressionKinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinomaAntioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macroEndocan silencing induces programmed cell death in hepatocarcinoma.NF‑κB is a key modulator in the signaling pathway of Borrelia burgdorferi BmpA‑induced inflammatory chemokines in murine microglia BV2 cells.NF-κB, the Importance of Being Dynamic: Role and Insights in Cancer.VHL and Hypoxia Signaling: Beyond HIF in Cancer.RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogrammingRenal Cell Carcinoma: Molecular AspectsIdentifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
P2860
Q27025321-38E51BAF-D3AC-49B8-BD81-A5E717EE6A4EQ33566604-FEB0D235-CED1-4044-A97C-7E499BC5E07DQ35546846-6504AFBE-D87B-42C6-8808-3D9824C72957Q36116625-621DFEA7-11D1-4975-98BA-A732F6B652BCQ37151107-AC32F223-75B6-4C48-96FB-71B0DB0CD9E3Q37364309-2B2365BA-5801-40D5-B31B-290FFEB3FA24Q38810926-525E870E-D48F-49C4-8AFF-4E9D3C7BF944Q39173616-38A72B58-28D5-4613-A7CB-4B337B54A089Q47139612-32AD93C0-3858-476E-810A-29BCEEA231A8Q49379063-50149C7D-FBED-4FCB-BCE5-44D74F0B8745Q52315473-792FA286-AB97-4D45-8547-CAE9513D5B15Q54943750-CF43F621-C927-4730-8510-104F97427B03Q55401042-0C8935A7-7B68-4FAB-B6D1-6B0145F19D6CQ57166997-1ADC6684-2865-4CD2-A580-3A583A5908F2Q57178229-FB341C99-E16B-4F70-BEC7-5265CAB82736Q57946325-B1663842-661D-409C-838D-58E7B96FE746
P2860
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@ast
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@en
type
label
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@ast
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@en
prefLabel
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@ast
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@en
P2093
P2860
P1433
P1476
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
@en
P2093
Alfred G Knudson
Dong-Hua Yang
Karthik Devarajan
Siddharth Balachandran
Suraj Peri
P2860
P304
P356
10.1371/JOURNAL.PONE.0076746
P407
P577
2013-10-07T00:00:00Z